Boston Biomedical Innovation Center (B-BIC) is a life sciences accelerator funded by the National Institutes of Health and our member institutions to increase the return on investment in research. We speed the translation of research technologies into products for doctors and their patients, for the good of society.
Our members are a consortium of academic medical centers in Boston including Brigham and Women’s Hospital, Harvard Medical School, Massachusetts General Hospital, and the Massachusetts Institute of Technology.
B-BIC provides funding for technology development and translational research, including regulatory, reimbursement, and business development aspects that are part of an overall commercialization strategy.
Keep pitch short and focused on the technology and its commercial application. Limit the discussion of preliminary results, and focus on the most relevant results with conclusions – not data. Present the science within the context of the business strategy. Keep details to a minimum and use visuals without words when possible. FAST PITCH FOR FUNDING is April 27th at 10:00am.…Read More
Potential for commercialization. Technology that addresses an unmet clinical need. Heart, Lung, Blood or Sleep indications. Preliminary data indicating promise of commercialization. Differentiation from competitors. IP filings, with institutions as the assignee. FAST PITCH FOR FUNDING is April 27th at 10:00am. This event provides you the opportunity to pitch a team of experts on your research. You…Read More
Are you ready to see your research move towards becoming a product? Fast Pitch for Funding is an event hosted by the Boston Biomedical Innovation Center, that provides you the opportunity to pitch a team of experts on your research. You will receive immediate feedback with the opportunity to apply for our grant programs which can provide up…Read More
Approximately 10,000 “blue babies” are given inhaled nitric oxide (NO) to treat Hypoxic Respiratory Failure each year. Other potential uses for inhaled NO include heart attacks, strokes, and malaria. But the technology necessary to deliver inhaled NO is available only in a limited number of countries, for those who can afford it, with physicians who…Read More
Platelets are the ‘bandaids’ of the bloodstream. They are the cells in your blood that stop you from bleeding and transfusions save the lives of millions every year. However, platelets can only be stored for 5-7.5 days because of bacterial contamination issues. To manage this, blood centers typically don’t keep more than a 1.5 days…Read More
Here is how B-BIC has helped this project. The money itself. It would be very difficult to raise money for this project from standard sources. Challenging questions from the reviewers. During the review of our preproposal, one challenge from the B-BIC point of contact was that we should design a Phase 3 trial for our…Read More
B-BIC has been a communicative and supportive organization to work with and the program is well designed. B-BIC has chosen targeted topics and emphasized commercial translation, making the program objectives clear. This aids the proposer in assessing likelihood of winning an award. The involvement of the program managers has been helpful and informative. The proposal…Read More
This grant has enabled me to advance the development of a medical device with a high potential clinical impact. This is consistent with my academic career, which centers on translational imaging research. The B-BIC grant has allowed me to engage with marketing and business advisors to learn more deeply about practical business principles necessary to…Read More
This project has advanced my professional development objectives by allowing me to learn much about the technology development and commercialization process. Beyond my conventional academic pursuits, involvement with the B-BIC program has broadened my horizons and underlined the importance of translating promising science from our laboratories towards practical/commercial applications. This work has enhanced my interest…Read More
The B-BIC program has been instrumental in helping us accelerate development of our bioreactor and achieve commercial proof of feasibility that would not have been possible within the same time frame by traditional non-dilutive funding mechanisms available at the time. B-BIC also allowed us to bridge academic and commercial requirements and resolve many practical hurdles…Read More
The B-BIC program has been invaluable in two ways. First, the grant support has allowed us to bring our device from early prototyping stage to full preclinical testing and now at a point where we can focus on achieving FDA clearance for clinical use. Second, the support of advisors have taught me to navigate the…Read More